Qi Wang
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Previous Organizations / Institutes
The organizations / institutes from the scholar's other articles in the past ten years
Qi Wang has a total of 31 co-authors. Here are the top co-authors by number of shared publications:
- Weifen Li
Key Laboratory of Animal Feed and Nutrition of Zhejiang Province, Institute of Animal Nutrition and Feed Sciences, College of Animal Sciences, Zhejiang University, Hangzhou 310058, China
2 shared publications - Baikui Wang
Key Laboratory of Systems Health Science of Zhejiang Province, School of Life Science, Hangzhou Institute for Advanced Study, University of Chinese Academy of Sciences
1 shared publication - Chuanbin Chen
Jiangxi Province Key Laboratory of Animal Nutrition and Feed, College of Animal Science and Technology, Jiangxi Agricultural University, Nanchang 330045, China
1 shared publication - Dandong Fang
Department of Critical Care Medicine, Jinling Hospital, Affiliated Hospital of Medical School, Nanjing University, Nanjing 210000, China
1 shared publication - Fei Wang
State Key Laboratory for Quality and Safety of Agro-Products, Institute of Agro-Product Safety and Nutrition, Zhejiang Academy of Agricultural Sciences, Hangzhou, China
1 shared publication Gaohuan Hou
Nanjing Jinling Hospital, Affiliated Hospital of Medical School, Nanjing University, Nanjing, China; School of Medicine, Southeast University, 210000 Nanjing, China
1 shared publication
Latest Publications
- Open Access
- 13 October 2026
- Published by MDPI AG in Antioxidants
- Vol. 15 (10) , 1317
Dietary Sanguinarine Enhances Antioxidant Capacity and Intestinal Barrier Function in Yellow-Feathered Broilers via Modulation of Microbiota-Associated Butyrate Signaling
Sanguinarine (SA), a bioactive benzophenanthridine alkaloid, has emerged as a potential alternative to antibiotic growth promoters; however, its effects on intestinal redox homeostasis and epithelial regeneration remain incompletely understood. This study investigated whether dietary SA could improve growth performance and intestinal health in yellow-feathered broilers and explored the potential involvement of gut microbiota-associated metabolite signaling pathways. Broilers were fed diets supplemented with different concentrations of SA (0.5 or 0.7 mg/kg feed), with an antibiotic-supplemented group serving as a comparator. High-dose SA (0.7 mg/kg feed) improved body weight and average daily gain while reducing the feed-to-gain ratio. SA also alleviated intestinal barrier dysfunction, as evidenced by reduced circulating diamine oxidase, D-lactate, and lipopolysaccharide levels, together with increased jejunal expression of tight-junction proteins and MUC2. In parallel, SA enhanced systemic and intestinal antioxidant capacity, as indicated by increased total antioxidant capacity and superoxide dismutase activity and decreased malondialdehyde accumulation. These changes were accompanied by increased immunoglobulin levels, reduced expression of pro-inflammatory mediators, and enhanced expression of anti-inflammatory cytokines. Cecal microbiota analysis demonstrated that SA markedly reshaped the microbial community, with enrichment of Faecalibacterium and depletion of several potentially unfavorable taxa. These microbial alterations, which were associated with improved antioxidant and immune indices, were accompanied by a selective increase in cecal butyrate levels. Consistently, SA enhanced intestinal GPR109A expression and upregulated genes associated with Wnt/β-catenin signaling. In LPS-challenged intestinal organoids, SA restored organoid growth and budding capacity, reduced apoptosis, increased Ki67-positive cell proliferation, and restored the expression of genes associated with Wnt/β-catenin signaling. Collectively, these findings indicate that dietary SA improves growth performance and intestinal homeostasis in broilers by attenuating oxidative stress and inflammation, strengthening epithelial barrier function, and supporting epithelial regeneration. The microbiota-associated butyrate/GPR109A/Wnt/β-catenin signaling pathway may contribute to these protective intestinal effects.
- 13 October 2026
- Published by MDPI AG in Antioxidants
- Vol. 15 (10) , 1317
Open AccessDietary Sanguinarine Enhances Antioxidant Capacity and Intestinal Barrier Function in Yellow-Feathered Broilers via Modulation of Microbiota-Associated Butyrate Signaling
Sanguinarine (SA), a bioactive benzophenanthridine alkaloid, has emerged as a potential alternative to antibiotic growth promoters; however, its effects on intestinal redox homeostasis and epithelial regeneration remain incompletely understood. This study investigated whether dietary SA could improve growth performance and intestinal health in yellow-feathered broilers and explored the potential involvement of gut microbiota-associated metabolite signaling pathways. Broilers were fed diets supplemented with different concentrations of SA (0.5 or 0.7 mg/kg feed), with an antibiotic-supplemented group serving as a comparator. High-dose SA (0.7 mg/kg feed) improved body weight and average daily gain while reducing the feed-to-gain ratio. SA also alleviated intestinal barrier dysfunction, as evidenced by reduced circulating diamine oxidase, D-lactate, and lipopolysaccharide levels, together with increased jejunal expression of tight-junction proteins and MUC2. In parallel, SA enhanced systemic and intestinal antioxidant capacity, as indicated by increased total antioxidant capacity and superoxide dismutase activity and decreased malondialdehyde accumulation. These changes were accompanied by increased immunoglobulin levels, reduced expression of pro-inflammatory mediators, and enhanced expression of anti-inflammatory cytokines. Cecal microbiota analysis demonstrated that SA markedly reshaped the microbial community, with enrichment of Faecalibacterium and depletion of several potentially unfavorable taxa. These microbial alterations, which were associated with improved antioxidant and immune indices, were accompanied by a selective increase in cecal butyrate levels. Consistently, SA enhanced intestinal GPR109A expression and upregulated genes associated with Wnt/β-catenin signaling. In LPS-challenged intestinal organoids, SA restored organoid growth and budding capacity, reduced apoptosis, increased Ki67-positive cell proliferation, and restored the expression of genes associated with Wnt/β-catenin signaling. Collectively, these findings indicate that dietary SA improves growth performance and intestinal homeostasis in broilers by attenuating oxidative stress and inflammation, strengthening epithelial barrier function, and supporting epithelial regeneration. The microbiota-associated butyrate/GPR109A/Wnt/β-catenin signaling pathway may contribute to these protective intestinal effects.
- Open Access
- 12 September 2025
- Published by MDPI AG in Microorganisms
- Vol. 13 (9) , 2136
Bacillus amyloliquefaciens SC06 Ameliorated Intestinal Mucosal Injury by Regulated Intestinal Stem Cells Proliferation and Differentiation via Activating Wnt/β-Catenin Signal Pathway in Clostridium perfringens-Challenged Mouse
The objective of our study was to verify the intervention effect of Bacillus amyloliquefaciens SC06 on NE by constructing a C. perfringens-induced intestinal damage mouse model. A total of 40 mice were randomly assigned to four treatments: CON (basal diet), CP (basal diet + C. perfringens), SC06 + CP (basal diet + SC06 + C. perfringens) and SC06 (basal diet + SC06). Our findings indicated that SC06 supplementation was effective in maintaining the integrity of the intestinal barrier, enhancing the antioxidant capacity of the intestine, reducing the generation of an inflammatory response, and suppressing enterocyte apoptosis in the presence of C. perfringens. Furthermore, SC06 supplementation enhanced the prefoliation of intestinal stem cells (ISC) and prompted their differentiation into goblet cells and Paneth cells. Moreover, our findings indicate that SC06 promotes the proliferation of C. perfringens-induced jejunum organoids and the expression of genes and proteins associated with ISC differentiation and regeneration. The mechanism by which SC06 modulates ISCs has been validated, and the results align with those obtained in vivo. In conclusion, the findings demonstrated that SC06 stimulates the proliferation and differentiation of ISCs through the activation of the Wnt/β-catenin signaling pathway, thereby accelerating epithelial regeneration and repair.
- 12 September 2025
- Published by MDPI AG in Microorganisms
- Vol. 13 (9) , 2136
Open AccessBacillus amyloliquefaciens SC06 Ameliorated Intestinal Mucosal Injury by Regulated Intestinal Stem Cells Proliferation and Differentiation via Activating Wnt/β-Catenin Signal Pathway in Clostridium perfringens-Challenged Mouse
The objective of our study was to verify the intervention effect of Bacillus amyloliquefaciens SC06 on NE by constructing a C. perfringens-induced intestinal damage mouse model. A total of 40 mice were randomly assigned to four treatments: CON (basal diet), CP (basal diet + C. perfringens), SC06 + CP (basal diet + SC06 + C. perfringens) and SC06 (basal diet + SC06). Our findings indicated that SC06 supplementation was effective in maintaining the integrity of the intestinal barrier, enhancing the antioxidant capacity of the intestine, reducing the generation of an inflammatory response, and suppressing enterocyte apoptosis in the presence of C. perfringens. Furthermore, SC06 supplementation enhanced the prefoliation of intestinal stem cells (ISC) and prompted their differentiation into goblet cells and Paneth cells. Moreover, our findings indicate that SC06 promotes the proliferation of C. perfringens-induced jejunum organoids and the expression of genes and proteins associated with ISC differentiation and regeneration. The mechanism by which SC06 modulates ISCs has been validated, and the results align with those obtained in vivo. In conclusion, the findings demonstrated that SC06 stimulates the proliferation and differentiation of ISCs through the activation of the Wnt/β-catenin signaling pathway, thereby accelerating epithelial regeneration and repair.
- Open Access
- 28 September 2021
- Published by MDPI AG in Antioxidants
- Vol. 10 (10) , 1545
Bacillus amyloliquefaciens SC06 Induced AKT–FOXO Signaling Pathway-Mediated Autophagy to Alleviate Oxidative Stress in IPEC-J2 Cells
Autophagy is a conserved proteolytic mechanism, which degrades and recycles damaged organs and proteins in cells to resist external stress. Probiotics could induce autophagy; however, its underlying molecular mechanisms remain elusive. Our previous study has found that BaSC06 could alleviate oxidative stress by inducing autophagy in rats. This research aimed to verify whether Bacillus amyloliquefaciens SC06 can induce autophagy to alleviate oxidative stress in IPEC-J2 cells, as well as explore its mechanisms. IPEC-J2 cells were first pretreated with 108 CFU/mL BaSC06, and then were induced to oxidative stress by the optimal dose of diquat. The results showed that BaSC06 significantly triggered autophagy, indicated by the up-regulation of LC3 and Beclin1 along with downregulation of p62 in IPEC-J2 cells. Further analysis revealed that BaSC06 inhibited the AKT–FOXO signaling pathway by inhibiting the expression of p-AKT and p-FOXO and inducing the expression of SIRT1, resulting in increasing the transcriptional activity of FOXO3 and gene expression of the ATG5–ATG12 complex to induce autophagy, which alleviated oxidative stress and apoptosis. Taken together, BaSC06 can induce AKT–FOXO-mediated autophagy to alleviate oxidative stress-induced apoptosis and cell damage, thus providing novel theoretical support for probiotics in the prevention and treatment of oxidative damage.
- 28 September 2021
- Published by MDPI AG in Antioxidants
- Vol. 10 (10) , 1545
Open AccessBacillus amyloliquefaciens SC06 Induced AKT–FOXO Signaling Pathway-Mediated Autophagy to Alleviate Oxidative Stress in IPEC-J2 Cells
Autophagy is a conserved proteolytic mechanism, which degrades and recycles damaged organs and proteins in cells to resist external stress. Probiotics could induce autophagy; however, its underlying molecular mechanisms remain elusive. Our previous study has found that BaSC06 could alleviate oxidative stress by inducing autophagy in rats. This research aimed to verify whether Bacillus amyloliquefaciens SC06 can induce autophagy to alleviate oxidative stress in IPEC-J2 cells, as well as explore its mechanisms. IPEC-J2 cells were first pretreated with 108 CFU/mL BaSC06, and then were induced to oxidative stress by the optimal dose of diquat. The results showed that BaSC06 significantly triggered autophagy, indicated by the up-regulation of LC3 and Beclin1 along with downregulation of p62 in IPEC-J2 cells. Further analysis revealed that BaSC06 inhibited the AKT–FOXO signaling pathway by inhibiting the expression of p-AKT and p-FOXO and inducing the expression of SIRT1, resulting in increasing the transcriptional activity of FOXO3 and gene expression of the ATG5–ATG12 complex to induce autophagy, which alleviated oxidative stress and apoptosis. Taken together, BaSC06 can induce AKT–FOXO-mediated autophagy to alleviate oxidative stress-induced apoptosis and cell damage, thus providing novel theoretical support for probiotics in the prevention and treatment of oxidative damage.